Ascend Gene & Cell Therapies’ $130 Million Series A Fundraise

Covington advised lead investors Abingworth and other syndicate members on the round.Ascend closed its $130 million Series A fundraise. Ascend will use the proceeds to launch as…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now